Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod IncfiledCriticalPfizer Prod Inc
Priority to DO2003000689ApriorityCriticalpatent/DOP2003000689A/en
Publication of DOP2003000689ApublicationCriticalpatent/DOP2003000689A/en
Una composición sólida de un fármaco de baja solubilidad y un polímero potenciador de la concentración tiene una porción del fármaco en un estado semiordenado.A solid composition of a low solubility drug and a concentration enhancing polymer has a portion of the drug in a semi-ordered state.
DO2003000689A2003-08-112003-08-11
PHARMACEUTICAL COMPOSITIONS OF SEMIORDENED AND POLYMER DRUGS
DOP2003000689A
(en)
INJECTABLE PHARMACEUTICAL COMPOSITION, DEPOSIT OF PROLONGED RELEASE, THAT INCLUDES A BENEFICIAL AGENT DISSOLVED OR DISPERSED IN A GEL CONSTITUTED BY A BIOEROSIONABLE AND BIOCOMPATIBLE POLYMER; AND A SOLVENT.
A PHARMACEUTICAL FORMULATION THAT INCLUDES AT LEAST A SELECTED COMPOSITE OF THE GROUP FORMED BY NON-BARBITURIC HYPNOTICS AND NON-BENZODIACEPINICS, AND MELATONIN
N-BENZODIOXOLYL, N-BENZODIOXANYL AND N-BENZODIOXEPINYL ARYLCARBOXAMIDE DERIVATIVES USEFUL IN THE TREATMENT OF DYSLIPIDEMIA AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME